Cox Alyssa B, Rawlinson Lee-Anne, Baird Alan W, Bzik Victoria, Brayden David J
UCD School of Agriculture, Food Science and Veterinary Medicine, University College Dublin, Belfield, Dublin 4, Ireland.
Pharm Res. 2008 Jan;25(1):114-22. doi: 10.1007/s11095-007-9354-9. Epub 2007 Jun 2.
The medium chain fatty acid, sodium caprate (C(10)), is a promising oral drug delivery agent that may promote permeability of peptides through increasing paracellular permeability of the intestinal epithelium. One safety concern is that it may permit co-absorption of by-stander agents including pathogens. The purpose of this in vitro study was to examine the effects of C(10) on rat intestinal ileal mucosae in the presence of co-administered Salmonella typhimurium in a low volume vertical Ussing chamber.
C(10) or S. typhimurium was added to rat ileal mucosae mounted in chambers and the flux of the paracellular flux of [(14)C]-mannitol examined. S. typhimurium adherence and uptake by ileal mucosae was also examined by counting. Bacterial growth curves were assessed in the presence of C(10). Minimum inhibitory- and bacteriocidal concentrations of C(10) were determined against a range of bacteria.
Apical addition of either C(10) or S. typhimurium to rat ileal mucosae mounted in modified diffusion chambers significantly increased the flux of [(14)C]-mannitol in a concentration-dependent fashion. Co-exposure with increasing concentrations of C(10) attenuated the Salmonella-induced increase in mannitol flux. Histological evaluation revealed that C(10) inhibited both adhesion and invasion of S. typhimurium to intestinal mucosae. Short term bacterial growth studies in the presence of C(10) showed evidence of concentration-dependent inhibition. C(10) was bacteriocidal in mM concentrations against S. typhimurium and selected gram positive and negative bacteria.
C(10) does not promote the permeation of a common bacterium across isolated intestinal tissue upon acute co-exposure. It prevents S. typhimurium attachment to epithelia and impedes growth of a range of different bacterial strains.
中链脂肪酸癸酸钠(C(10))是一种很有前景的口服药物递送剂,它可能通过增加肠道上皮细胞的细胞旁通透性来促进肽的通透性。一个安全问题是它可能会使包括病原体在内的旁观者物质共同吸收。这项体外研究的目的是在低容量垂直Ussing室中,研究在共同给予鼠伤寒沙门氏菌的情况下,C(10)对大鼠回肠黏膜的影响。
将C(10)或鼠伤寒沙门氏菌添加到安装在室中的大鼠回肠黏膜中,并检测[(14)C]-甘露醇的细胞旁通量。还通过计数来检测鼠伤寒沙门氏菌对回肠黏膜的黏附和摄取。在有C(10)存在的情况下评估细菌生长曲线。测定C(10)对一系列细菌的最低抑菌浓度和杀菌浓度。
向安装在改良扩散室中的大鼠回肠黏膜顶端添加C(10)或鼠伤寒沙门氏菌,均以浓度依赖性方式显著增加了[(14)C]-甘露醇的通量。与浓度不断增加的C(10)共同暴露可减弱沙门氏菌诱导的甘露醇通量增加。组织学评估显示,C(10)抑制了鼠伤寒沙门氏菌对肠道黏膜的黏附和侵袭。在有C(10)存在的情况下进行的短期细菌生长研究显示出浓度依赖性抑制的证据。C(10)在毫摩尔浓度下对鼠伤寒沙门氏菌以及选定的革兰氏阳性和阴性细菌具有杀菌作用。
急性共同暴露时,C(10)不会促进常见细菌穿过分离的肠道组织的渗透。它可防止鼠伤寒沙门氏菌附着于上皮细胞,并阻碍一系列不同细菌菌株的生长。